Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Dianthus Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Dianthus Therapeutics Inc
Rating: 2.09358325
Author: Trendlyne DVM scores

about

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, fo...

104.75 1.99 (1.94%)

New 52W High in past week

477.0K

XNAS Volume

XNAS 23 Jul, 2026 3:55 PM (EDT)

Not Eligible

Expensive Valuation

6.3 / 100

Technically Bullish

77.4 / 100

129

1Yr Price target upside is 23%

12 analysts

Dianthus Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Dianthus Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, fo...

New 52W High in past week

SWOT Analysis

Dianthus Therapeutics Inc Live Price Chart

Dianthus Therapeutics Inc Live Price Chart